These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11012844)

  • 1. Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats.
    Otagiri A; Wakabayashi I; Shibasaki T
    J Neuroendocrinol; 2000 Oct; 12(10):1022-6. PubMed ID: 11012844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
    Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
    Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E
    Yamaguchi N; Mimura K; Okada S
    Eur J Pharmacol; 2019 Nov; 863():172693. PubMed ID: 31560870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats.
    Kikusui T; Takeuchi Y; Mori Y
    Physiol Behav; 2000 Nov 1-15; 71(3-4):323-8. PubMed ID: 11150564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrahypothalamic corticotropin-releasing hormone mediates (-)-nicotine-induced elevation of plasma corticosterone in rats.
    Okada S; Shimizu T; Yokotani K
    Eur J Pharmacol; 2003 Jul; 473(2-3):217-23. PubMed ID: 12892841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
    Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
    Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of CRFR
    Hollis F; Sevelinges Y; Grosse J; Zanoletti O; Sandi C
    eNeuro; 2016; 3(5):. PubMed ID: 27844053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats.
    Okada S; Yamaguchi N
    Auton Neurosci; 2017 Mar; 203():74-80. PubMed ID: 28202248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala.
    Thompson BL; Erickson K; Schulkin J; Rosen JB
    Behav Brain Res; 2004 Mar; 149(2):209-15. PubMed ID: 15129783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a corticotropin-releasing factor receptor 1 antagonist on the fear conditioning response in low- and high-anxiety rats after chronic corticosterone administration.
    Skórzewska A; Wisłowska-Stanek A; Lehner M; Turzyńska D; Sobolewska A; Krząścik P; Szyndler J; Maciejak P; Płaźnik A
    Stress; 2019 Jan; 22(1):113-122. PubMed ID: 30345859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABA
    Yamaguchi N; Mimura K; Okada S
    Eur J Pharmacol; 2019 Apr; 848():88-95. PubMed ID: 30685430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
    Lu L; Liu D; Ceng X
    Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus.
    Jiang Z; Rajamanickam S; Justice NJ
    J Neurosci; 2018 Feb; 38(8):1874-1890. PubMed ID: 29352046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats.
    Xu JF; Chen XQ; Du JZ; Wang TY
    Peptides; 2005 Apr; 26(4):639-46. PubMed ID: 15752579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats.
    Kaneko K; Kawana S; Arai K; Shibasaki T
    Exp Dermatol; 2003 Feb; 12(1):47-52. PubMed ID: 12631246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat.
    Nijsen MJ; Croiset G; Diamant M; Stam R; Kamphuis PJ; Bruijnzeel A; de Wied D; Wiegant VM
    Eur J Pharmacol; 2000 Feb; 389(1):89-98. PubMed ID: 10686300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
    Sekino A; Ohata H; Mano-Otagiri A; Arai K; Shibasaki T
    Psychopharmacology (Berl); 2004 Oct; 176(1):30-8. PubMed ID: 15071721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats.
    Hotta M; Shibasaki T; Arai K; Demura H
    Brain Res; 1999 Mar; 823(1-2):221-5. PubMed ID: 10095032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traumatic Stress Promotes Hyperalgesia via Corticotropin-Releasing Factor-1 Receptor (CRFR1) Signaling in Central Amygdala.
    Itoga CA; Roltsch Hellard EA; Whitaker AM; Lu YL; Schreiber AL; Baynes BB; Baiamonte BA; Richardson HN; Gilpin NW
    Neuropsychopharmacology; 2016 Sep; 41(10):2463-72. PubMed ID: 27013358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
    Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Lianyi L; Wakiguchi H; Yokotani K
    Eur J Pharmacol; 2008 Jun; 587(1-3):322-9. PubMed ID: 18423439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.